Clinical Trial Update: A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents [Phase 3]

View source ↗

Summary

Phase III clinical study of valsartan oral solution for treating essential hypertension in children and adolescents is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Valsartan oral solution (Valsartan)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Essential Hypertension | Phase 3 | Status: ENROLLING_BY_INVITATION